Cannabis stocks surge on rescheduling news; Aurora Cannabis jumps 16% despite no US strategy. Read why I'm maintaining my ...

Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.

Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may ...

Shares of Canadian cannabis companies climbed in the premarket trading on Monday after The Wall Street Journal reported that President Donald Trump is considering whether to reschedule marijuana as a ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...

Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that ...

Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...

Aurora Cannabis' problems continue to mount. Earlier this week, the company announced that it had fully completed a $250 million (that's U.S.) at-the-market (ATM) offering first announced in April.

When recreational cannabis was legalized, the city of Aurora decided dispensary hours should be 8 a.m. to 10 p.m. "The hype is still there, people are still consuming," said Starbuds Store ...